Zobrazeno 1 - 10
of 439
pro vyhledávání: '"H.T Mouridsen"'
Autor:
J.-M. Nabholtz
Publikováno v:
European Journal of Cancer. 40:1097
Autor:
Nabholtz, J.-M.
Publikováno v:
In European Journal of Cancer 2004 40(7):1097-1097
Publikováno v:
European journal of cancer (Oxford, England : 1990). 39(7)
Two immunoassays for quantitation of the biological markers uPA and PAI-1 were evaluated for their use with detergent extracts of breast cancer tissue. Both assays were based on murine monoclonal capture antibodies and rabbit polyclonal detector anti
Autor:
Carsten Rose, B. Kristensen, Jens O. Andersen, Bent Ejlertsen, H.T. Mouridsen, Inger Højris, K Møholt, Steinbjørn Hansen, Mogens Kjaer
Publikováno v:
Ejlertsen, B, Højris, I, Hansen, S, Møholt, K, Kristensen, B, Mouridsen, H T, Andersen, J, Rose, C & Kjær, M 2003, ' Combined epirubicin and vinorelbine as first-line therapy in metastatic breast cancer: a pilot study performed by the Danish Breast Cancer Cooperative Group ', Breast, vol. 12, no. 1, pp. 42-50 . https://doi.org/10.1016/S0960-9776(02)00180-7
Ejlertsen, B, Hojris, I, Hansen, S, Moholt, K, Kristensen, B, Mouridsen, H T, Andersen, J, Rose, C & Kjaer, M 2003, ' Combined epirubicin and vinorelbine as first-line therapy in metastatic breast cancer : a pilot study performed by the Danish Breast Cancer Cooperative Group ', Breast, vol. 12, no. 1, pp. 42-50 . https://doi.org/10.1016/S0960-9776(02)00180-7
Ejlertsen, B, Hojris, I, Hansen, S, Moholt, K, Kristensen, B, Mouridsen, H T, Andersen, J, Rose, C & Kjaer, M 2003, ' Combined epirubicin and vinorelbine as first-line therapy in metastatic breast cancer : a pilot study performed by the Danish Breast Cancer Cooperative Group ', Breast, vol. 12, no. 1, pp. 42-50 . https://doi.org/10.1016/S0960-9776(02)00180-7
This pilot study investigated the tolerability and efficacy of increasing doses of epirubicin and vinorelbine as first-line chemotherapy for metastatic breast cancer. Acute toxicity was manageable at all dose levels for combinations of epirubicin 60-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e388a6862b63a433396191c95b1fb84c
https://pure.au.dk/portal/da/publications/combined-epirubicin-and-vinorelbine-as-firstline-therapy-in-metastatic-breast-cancer-a-pilot-study-performed-by-the-danish-breast-cancer-cooperative-group(12538240-9561-11da-bee9-02004c4f4f50).html
https://pure.au.dk/portal/da/publications/combined-epirubicin-and-vinorelbine-as-firstline-therapy-in-metastatic-breast-cancer-a-pilot-study-performed-by-the-danish-breast-cancer-cooperative-group(12538240-9561-11da-bee9-02004c4f4f50).html
Autor:
Anita Niebuhr, Kirsten Fenger, R.B. Barkardottir, B. Ejlertsen, Åke Borg, J.H. Olsen, H.T. Mouridsen, Erik Niebuhr, K.V. Nielsen, S. Klausen, K. Winther, Theresa Larriba Harboe, Jon Thor Bergthorsson
Publikováno v:
Journal of medical genetics. 38(6)
INTRODUCTIONA small fraction of breast cancer is the result of germline mutations in theBRCA1 and BRCA2cancer susceptibility genes. Mutation carriers frequently have a positive family history of breast and ovarian cancer, are often diagnosed at a you
Autor:
H.A. Chaudri-Ross, H.T. Mouridsen
Publikováno v:
European Journal of Cancer. 40:1095-1096
Autor:
H.T. Mouridsen
Publikováno v:
European Journal of Cancer Supplements. 1:263-264
Autor:
H.T. Mouridsen, Peer Christiansen, Anne Vibeke Lænkholm, BV Offersen, Maj-Britt Jensen, Bent Ejlertsen, Karsten Bjerre, M.E. Kvistgaard, Birgitte Bruun Rasmussen, S. Møller, D.B. Toftdahl, Niels Kroman
Publikováno v:
The Breast. 20:S14
Autor:
H.T. Mouridsen
Publikováno v:
European journal of cancer (Oxford, England : 1990). (4)
Systemic adjuvant therapy has improved the prognosis of patients with primary breast cancer. Meta-analyses have demonstrated that approximately one fourth of deaths can be avoided among younger women treated with multiple cytotoxic drug regimens and
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.